Hovid Berhad operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hovid Berhad with three other
companies in this sector in Malaysia:
YSP Southeast Asia Holding Bhd
sales of 237.07 million Malaysian Ringgits [US$55.30 million]
of which 82%
Kotra Industries Bhd
(160.23 million Malaysian Ringgits [US$37.38 million]
CCM Duopharma Biotech Berhad
(312.94 million Malaysian Ringgits [US$73.00 million]
of which 100%
was Manufacturing of Pharmaceutical Products).
Hovid Berhad reported sales of 189.03 million Malaysian Ringgits (US$44.09 million)
June of 2016.
a very small
increase of 0.3%
versus 2015, when the company's sales were 188.41 million Malaysian Ringgits.
Sales at Hovid Berhad have increased during each of the previous five years
(and since 2011, sales have increased a total of 23%).